DME, DR, and Next-Generation Therapies

Wet AMD and Next-Generation Therapies

Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 3 of 3)

Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 2 of 3)

Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 1 of 3)

Global Discussions in GA: Educating Patients and Encouraging Follow-Up

Global Discussions in GA: Referral Patterns and Fellow-Eye Monitoring

Endophthalmitis Rates With and Without Antibiotic Prophylaxis

The Nuts and Bolts of GA Therapy: Wrapping Up the Conversation

AAO '25: GLP-1s and AMD, and Parity in Retina Care

Late-Breaking Talks at AAO '25: Phase 3 for Uveitic Macular Edema and GATHER2 OLE

AAO '25: Dry AMD Pipeline and Oral Treatment for Stargardt Disease

The Nuts and Bolts of GA Therapy: The Discussions Continue

Late-Breaking Talks at AAO '25: Gene Therapy for RP and NPDR

New Retina Radio Journal Club w/ VBS: Time-Driven Cost Analysis of PRP: Dollars, Minutes, and Patient Care

The Nuts and Bolts of GA Therapy: The Opening Sessions

Keeping Patients at the Center of GA Therapy: Preserving Vision vs Restoring Vision

Keeping Patients at the Center of GA Therapy: Dosing Schedules, AREDS Vitamins, and Photobiomodulation

Keeping Patients at the Center of GA Therapy: Patient Education and Setting Expectations

Keeping Patients at the Center of GA Therapy: Social Impact and Early Intervention